Visby Medical is at the forefront of developing innovative diagnostic technologies aimed at transforming the way infectious diseases are detected and managed. The company specializes in point-of-care testing solutions that leverage advanced microfluidics and molecular diagnostics. Their flagship product is a portable, rapid testing device that can deliver accurate results for various infections, including sexually transmitted infections (STIs), in a matter of minutes. This technology is designed to provide healthcare professionals with immediate insights, enabling timely treatment decisions and improving patient outcomes.

The scientific foundation of Visby Medical's technology is rooted in its proprietary platform, which integrates sophisticated sample processing and amplification techniques. This allows for the detection of pathogens at low concentrations, ensuring high sensitivity and specificity. The company emphasizes the importance of user-friendly design, making their devices accessible for use in diverse healthcare settings, from clinics to remote locations. By combining cutting-edge technology with practical applications, Visby Medical aims to enhance the efficiency of diagnostic testing and ultimately improve public health responses to infectious diseases.

United States

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company developed a proprietary technology platform that is the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious respiratory and sexually transmitted infections.

Visby Medical

Company Details